Darden Restaurants Inc (DRI) Q3 2026 Earnings Call Transcript

Why It Matters

The results demonstrate Enhabit’s ability to grow high‑margin hospice services while strengthening its balance sheet, positioning the firm for continued market share gains and strategic flexibility.

Key Takeaways

• Revenue $263.6M, up 3.9% YoY
• Hospice EBITDA +72% YoY, margin 27.3%
• Net debt/EBITDA ratio fell to 3.9x
• Visits per episode pilot cut visits to 13.4
• Full-year guidance raised, revenue $1.058‑$1.063B

Pulse Analysis

The post‑acute care landscape remains volatile, with CMS proposing a new home‑health rule and payers renegotiating rates. Enhabit’s proactive contract strategy—securing two rate‑increase agreements in Q3 without disrupting patient access—illustrates how providers can mitigate reimbursement risk while preserving census growth. This approach is especially critical as Medicare Advantage penetration rises and fee‑for‑service volumes fluctuate, making payer diversification a competitive advantage.

Enhabit’s operational highlights underscore a dual‑track growth model. Hospice revenue surged 20% to $63.1 million, and adjusted EBITDA leapt 72%, reflecting both higher census and improved unit economics. Meanwhile, the visits‑per‑episode pilot, rolled out across 83 branches, trimmed average visits from 15 to 13.4, signaling a scalable efficiency lever that can offset margin pressure from lower unit revenues in home health. The modest decline in home‑health adjusted EBITDA is largely attributable to temporary payer disruptions, which the company expects to normalize.

Financially, the firm’s leverage improved markedly, with net debt‑to‑EBITDA dropping to 3.9× and cash on hand rising by $49.2 million. This stronger balance sheet not only reduces interest expense but also expands capacity for strategic investments, including technology upgrades or bolt‑on acquisitions. The raised full‑year revenue outlook of $1.058‑$1.063 billion and adjusted EBITDA target of $106‑$109 million signal confidence in sustaining growth momentum. Stakeholders should watch how Enhabit leverages its liquidity to accelerate de novo expansion and further embed efficiency initiatives across its home‑health platform.